SAB Biotherapeutics Statistics
Total Valuation
SABS has a market cap or net worth of $28.06 million. The enterprise value is $2.36 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SABS has 9.23 million shares outstanding. The number of shares has increased by 74.13% in one year.
Current Share Class | 9.23M |
Shares Outstanding | 9.23M |
Shares Change (YoY) | +74.13% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 16.26% |
Owned by Institutions (%) | 20.53% |
Float | 6.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 17.46 |
Forward PS | n/a |
PB Ratio | 0.77 |
P/TBV Ratio | 0.77 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.56 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.12.
Current Ratio | 3.69 |
Quick Ratio | 3.46 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -159.11 |
Financial Efficiency
Return on equity (ROE) is -174.73% and return on invested capital (ROIC) is -105.52%.
Return on Equity (ROE) | -174.73% |
Return on Assets (ROA) | -78.80% |
Return on Capital (ROIC) | -105.52% |
Revenue Per Employee | $26,539 |
Profits Per Employee | -$799,428 |
Employee Count | 57 |
Asset Turnover | 0.04 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.96% in the last 52 weeks. The beta is 0.64, so SABS's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | -63.96% |
50-Day Moving Average | 2.97 |
200-Day Moving Average | 3.53 |
Relative Strength Index (RSI) | 47.55 |
Average Volume (20 Days) | 83,196 |
Short Selling Information
The latest short interest is 58,763, so 0.64% of the outstanding shares have been sold short.
Short Interest | 58,763 |
Short Previous Month | 79,819 |
Short % of Shares Out | 0.64% |
Short % of Float | 0.96% |
Short Ratio (days to cover) | 0.54 |
Income Statement
In the last 12 months, SABS had revenue of $1.51 million and -$45.57 million in losses. Loss per share was -$5.28.
Revenue | 1.51M |
Gross Profit | -25.38M |
Operating Income | -51.78M |
Pretax Income | -40.32M |
Net Income | -45.57M |
EBITDA | -46.91M |
EBIT | -51.78M |
Loss Per Share | -$5.28 |
Full Income Statement Balance Sheet
The company has $30.40 million in cash and $4.52 million in debt, giving a net cash position of $25.88 million or $2.80 per share.
Cash & Cash Equivalents | 30.40M |
Total Debt | 4.52M |
Net Cash | 25.88M |
Net Cash Per Share | $2.80 |
Equity (Book Value) | 36.90M |
Book Value Per Share | 4.00 |
Working Capital | 23.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$38.21 million and capital expenditures -$349,749, giving a free cash flow of -$38.56 million.
Operating Cash Flow | -38.21M |
Capital Expenditures | -349,749 |
Free Cash Flow | -38.56M |
FCF Per Share | -$4.18 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -3,422.67% |
Pretax Margin | -3,012.27% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,344.30% |
Dividends & Yields
SABS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -74.13% |
Shareholder Yield | -74.13% |
Earnings Yield | -159.41% |
FCF Yield | -134.88% |
Analyst Forecast
The average price target for SABS is $12.40, which is 307.90% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.40 |
Price Target Difference | 307.90% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jan 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
SABS has an Altman Z-Score of -4.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.16 |
Piotroski F-Score | 2 |